Most here agree that the answer to that question is going to be a big, fat "it depends", or "depended" if talking in the past tense. Those paying attention to the communications, as vague as they can be, knew what near-term announcements could entail, positive or negative.In my opinion... Moving forward a BLA resubmission can put this over a dollar and if it's a quick approval that catches shorts of guard, say a few weeks into a class 1 resubmission that already had a shorter timeline, this could easily go into the multiple dollars.In my opinion... A submission for Heart Failure AA would have the same effect, but a much larger response on approval considering the size of the market.So that 86c in 3 weeks - yes a lot of people here recognised the potential.
Could it happen again? It depends.
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-546
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.015(1.30%) |
Mkt cap ! $1.341B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.19 | $1.15 | $2.230M | 1.910M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 42264 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 86209 | 25 |
View Market Depth
| Last trade - 12.43pm 23/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |